Marinol (Dronabinol) - Summary

MARINOL SUMMARY

MARINOL^®
(dronabinol)
Capsules

Dronabinol is a cannabinoid designated chemically as (6 aR-trans) -6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6 H -dibenzo[ b,d ]pyran-1-ol.

MARINOL® (Dronabinol) Capsules is indicated for the treatment of:

1. anorexia associated with weight loss in patients with AIDS; and
2. nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.

MARINOL NEWS HIGHLIGHTS

Published Studies Related to Marinol (Dronabinol)

Efficacy of Dronabinol as an Adjuvant Treatment for Chronic Pain Patients on Opioid Therapy. [2008.03]

Patients with chronic pain on opioid therapy taking dronabinol: incidence of false negatives using radioimmunoassay. [2008.01]

Efficacy of Dronabinol as an Adjuvant Treatment for Chronic Pain Patients on Opioid Therapy. [2007.12.12]

Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep. [2007.08.15]

Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. [2007.03]

more>>

Clinical Trials Related to Marinol (Dronabinol)

Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for Patients on Opioids for Chronic Pain [Active, not recruiting]

Ph1 Marinol Interaction Study - Part 1 - 1 [Active, not recruiting]

Free Dronabinol Treatment for Marijuana Addiction [Recruiting]

A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome [Completed]

Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal [Not yet recruiting]

more>>